Global Electronic Clinical Outcome Assessment Solutions Market By Deployment mode (On-premise and Web & Cloud-based) By End-User (Hospitals/Healthcare providers, CROs, and Other End-Use), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Electronic Clinical Outcome Assessment Solutions Market Overview:

The global market for electronic clinical outcomes assessment solutions was valued at USD 12,900 million in 2021. It is forecast to grow at a compound annual growth rate (CAGR), of 15.6% between 2022-2023.

A growing number of Clinical Trials, the increasing need to improve compliance and effectively capture and manage medical information, the need to reduce costs, and an increase in R&D activities are expected to drive market growth.

Global Electronic Clinical Outcome Assessment Solutions Scope:

Deployment Mode Analysis

The largest revenue share in the market was achieved by cloud and web-based delivery modes in 2021. This is due to the many benefits associated with its use. These solutions provide key features such as remote access to patients’ health information and sharing of information in order to limit data misuse or address issues at critical points. These solutions offer many other benefits, including centralization of data and scalability, lower costs, uptime consistency, and consistent uptime.

On-premise solutions on the other side are preferred due to their data security, localization, and greater control over data. Segment growth could be impeded by high implementation costs and insufficient infrastructure.

Market growth is expected to be driven by a growing number of companies, and the initiatives they deploy. IBM, IQVIA Inc., Medidata Solutions, Inc., Clario, ArisGlobal, Signant Health, etc. are some of the most important companies.

End-User Analysis

Contract Research Organizations (CROs), with the highest revenue share in 2021, saw significant growth. This is due to the outsourcing by major biopharmaceutical or medical device companies of clinical research management. IQVIA eCOA, for instance, supports real-time patient data collection in clinical research and studies. The COVID-19 project saw several trials of the solution that allowed real-time data capture at a cost-effective and remote location.

Electronic data capturing services are being adopted by hospitals and healthcare providers to increase patient engagement in research studies. eCOA digitally collects both doctors’ and patients’ information. eCOA provides information on handy devices such as tablets & smartphones, browsers, interactive voice response systems, and patients’ Bring-Your-Own-Device (BYOD).

It is based on secure systems that conform to regulatory guidelines when capturing clinical information. The key growth factors for hospital implementation of eCOA are the adoption of mHealth technology and BYOD.

Key Market Segments:

By Deployment Mode

• On-premise
• Web & Cloud-based

By End-User

• Hospitals/Healthcare providers
• CROs
• Pharmaceutical and Biotechnology Firms
• Medical Device Companies
• Others

Market Dynamics:

The 2020 COVID-19 pandemic had a negative impact on the conduct and management of clinical research trials. Market stakeholders adopted eClinical solutions and other measures to address these issues and maintain clinical research. The digitalization of clinical trials was also facilitated by the pandemic.

Many sponsors, CROs, medical device firms, and biopharma companies began using eClinical to efficiently and remotely collect, manage, and analyze data. eCOAs enable remote patient data collection.

Medical research professionals are increasingly using eCOA to drive market growth. Due to increasing research studies, there is a growing need for a centralized data collection system that can improve patient engagement. Market demand will increase over the forecast time.

The electronic patient report outcomes (ePROs), a tool that allows patients to share and collect trial data as well as to use embedded tools like alerts and reminders to integrate the trial into their daily lives, was a valuable tool during the pandemic. Future market growth will be driven by technological advances such as gamification, reward, and Alexa-style tools.

Due to the increasing pressure on pharmaceutical companies to reduce overall drug development costs, they are more inclined towards electronic data capture than paper-based methods. The data capturing using eCOA platforms improves quality, harmonizes data collection processes, and provides significant value to its users for data analysis.

With higher patient compliance, electronic-based services can be used to capture and analyze data. They can also reduce site monitoring costs and eliminate data variance. These solutions streamline information and improve data quality by capturing the information in an organized way. These benefits are expected to increase the demand for products over the next few years.

Regional Analysis

North America was expected to be the largest regional market by 2021. In the next few years, new drug development activities will be driven by technologically advanced research centers, medical device manufacturers, and hospitals as well as better healthcare establishments.

In 2021, the U.S. accounted for the largest North American market. This was due to its higher adoption of eClinical platforms. In the next few years, key users will likely take initiative to adopt eClinical platforms.

The Asia Pacific is witnessing a large patient pool, a flow of investment from MNCs, CROs, and outsourcing to support clinical research, drug discovery, and other areas. This will increase the market growth. China and India are the two largest markets region for clinical research outsourcing by major biotech & pharma companies. This is expected to be a significant contributor to the increasing demand for eCOA services over the forecast period.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

There are many companies that compete in the electronic clinical outcomes assessment solutions market. They assist in strategic initiatives like customer acquisition, upgradation, partnerships & collaborations, mergers or acquisitions, as well as sales & marketing activities.

Assisted unveiled an enhanced version of its cloud-based eCOA platform on June 20, 2021. The updated version features enhancements that are available for patients, sponsors, and clinicians. It is built to be compliant with the best practices for secure collection of clinical results.

IBM Clinical Development Suite offers a comprehensive solution that allows for the management of clinical data. It is available to a wide variety of users. It features eCOA, which replaces conventional reporting methods and improves clinical outcomes. The market leader in electronic clinical outcome assessments solutions worldwide is:

Маrkеt Кеу Рlауеrѕ:

• IBM
• IQVIA Inc
• Medidata Solutions, Inc
• Clario
• ArisGlobal
• Signant Health
• TransPerfect
• Cloudbyz
• Other Key Players

For the Electronic Clinical Outcome Assessment Solutions Market research study, the following years have been considered to estimate the market size: